• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Cardinal Health

Cardinal Health

Johnson Growth JGRWX 2 Star

Last Price$29.48Day Change (%)0.37%
Open Price$29.48Day Change ($)0.11
Day Range29.48–29.4852-Week Range24.47–29.71

As of Fri 01/20/2017 | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Biopsy Needles Market Forecast (2016-2022) - Driven by Increasing Healthcare Expenditure - Key Vendors are Creganna, Angiotech & Hologic - Research and Markets

    Biopsy Needles Market Forecast (2016-2022) - Driven by Increasing Healthcare Expenditure - Key Vendors are Creganna, Angiotech & Hologic - Research and Markets

  2. McKesson to Pay $150 Million for Failing to Report 'Suspicious' Drug Orders -- Update

    McKesson to Pay $150 Million for Failing to Report 'Suspicious' Drug Orders -- Update

  3. McKesson to Pay $150 Million for Failing to Report 'Suspicious' Drug Orders

    McKesson to Pay $150 Million for Failing to Report 'Suspicious' Drug Orders

  4. NovaBay Pharmaceuticals Announces Preliminary Sales for the Fourth Quarter of 2016

    NovaBay Pharmaceuticals Announces Preliminary Sales for the Fourth Quarter of 2016

  5. Osterweis Investment Outlook: Can Equities Continue Their Rise?

    Cardinal Health CAH reported good second-quarter results, and we are maintaining our fair value estimate. Revenue and earnings were both strong, as all four divisions posted double-digit earnings increases over the same quarter last year. Cardinal also announced that it has agreed to sell its ...

  6. Don’t Ignore Higher Taxes Until Tax Day

    PSS World Medical PSSI held its annual investor meeting this week. The firm's management offered valuable insight into the company's strategy and provided a detailed forecast for 2008. The update did not change our take on PSS' competitive position, and the earnings forecast was largely in line ...

  7. Credit Market Outlook: Bonds Priced for the Benign

    Corporate credit spreads are fairly valued--albeit at the tight end of the range that we view as fairly valued.

  8. Have You Hugged Your Struggling Fund Today?

    Poor performance can indicate that stocks are on sale.

  9. What's the Best Way to Play a Large-Growth Rally?

    You'll be surprised at which funds are poised for a large-growth rebound.

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.